AU607012B2 - Agents for treating high blood pressure and cardiac insufficiency - Google Patents

Agents for treating high blood pressure and cardiac insufficiency Download PDF

Info

Publication number
AU607012B2
AU607012B2 AU24438/88A AU2443888A AU607012B2 AU 607012 B2 AU607012 B2 AU 607012B2 AU 24438/88 A AU24438/88 A AU 24438/88A AU 2443888 A AU2443888 A AU 2443888A AU 607012 B2 AU607012 B2 AU 607012B2
Authority
AU
Australia
Prior art keywords
blood pressure
group
agents
tho
cardiac insufficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU24438/88A
Other languages
English (en)
Other versions
AU2443888A (en
Inventor
Peter Rose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of AU2443888A publication Critical patent/AU2443888A/en
Application granted granted Critical
Publication of AU607012B2 publication Critical patent/AU607012B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • External Artificial Organs (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
AU24438/88A 1987-10-30 1988-10-28 Agents for treating high blood pressure and cardiac insufficiency Ceased AU607012B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3736866 1987-10-30
DE19873736866 DE3736866A1 (de) 1987-10-30 1987-10-30 Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz

Publications (2)

Publication Number Publication Date
AU2443888A AU2443888A (en) 1989-05-04
AU607012B2 true AU607012B2 (en) 1991-02-21

Family

ID=6339463

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24438/88A Ceased AU607012B2 (en) 1987-10-30 1988-10-28 Agents for treating high blood pressure and cardiac insufficiency

Country Status (11)

Country Link
US (1) US5516773A (enExample)
EP (2) EP0471388B1 (enExample)
JP (1) JP2665357B2 (enExample)
KR (1) KR960011240B1 (enExample)
AT (1) ATE91418T1 (enExample)
AU (1) AU607012B2 (enExample)
DE (2) DE3736866A1 (enExample)
DK (1) DK603688A (enExample)
HK (1) HK175896A (enExample)
HU (1) HU203282B (enExample)
ZA (1) ZA888090B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018401A1 (de) 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
DE60200160T2 (de) * 2002-07-25 2004-11-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
WO2014122248A1 (en) 2013-02-11 2014-08-14 Boehringer Ingelheim Vetmedica Gmbh Kit-of-parts

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0065229A1 (de) * 1981-05-19 1982-11-24 Dr. Karl Thomae GmbH Neue Benzazepinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639718C2 (de) * 1976-09-03 1987-03-05 Dr. Karl Thomae Gmbh, 7950 Biberach 1-[6,7-Dimethoxy-3,4-dihydro-2H-isochinolin-1-on-2-yl]-3-[N-methyl-N-(2-(3,4-dimethoxy-phenyl)-äthyl)-amino]-propan, dessen physiologisch verträgliche Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0065229A1 (de) * 1981-05-19 1982-11-24 Dr. Karl Thomae GmbH Neue Benzazepinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel
AU551509B2 (en) * 1981-05-19 1986-05-01 Dr. Karl Thomae Gmbh Benzazepine derivatives

Also Published As

Publication number Publication date
EP0471388B1 (de) 1993-07-14
EP0471388A2 (de) 1992-02-19
ATE91418T1 (de) 1993-07-15
AU2443888A (en) 1989-05-04
DE3882381D1 (enExample) 1993-08-19
JP2665357B2 (ja) 1997-10-22
EP0313945A3 (de) 1990-12-05
HU203282B (en) 1991-07-29
HK175896A (en) 1996-09-27
DE3736866A1 (de) 1989-05-11
DK603688A (da) 1989-05-01
EP0471388A3 (de) 1992-03-11
DK603688D0 (da) 1988-10-28
KR960011240B1 (ko) 1996-08-21
US5516773A (en) 1996-05-14
EP0313945A2 (de) 1989-05-03
JPH02138123A (ja) 1990-05-28
HUT48464A (en) 1989-06-28
ZA888090B (en) 1990-07-25
KR890006234A (ko) 1989-06-12

Similar Documents

Publication Publication Date Title
ES2227865T3 (es) Combinaciones terapeuticas que comprende amlodipina y atorvastatina.
US20060258640A1 (en) Use of Flibanserin in the treatment of chronic pain
JPWO1992021345A1 (ja) 抗腫瘍効果増強のための及び腫瘍治療のための組成物
CN1272788A (zh) 治疗糖皮质素功能失调相关性精神病的方法
US20230381173A1 (en) Methods and pharmaceutical composition for treating diseases
WO1994012184A1 (en) Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
WO2008116890A2 (en) Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
JP2018509474A (ja) インダン酢酸誘導体を用いる肝疾患の治療方法
US6451813B1 (en) Treatment of gastroparesis in certain patient groups
KR0150649B1 (ko) 술폰아닐리드 유도체 및 의약
CN115192573A (zh) 盐酸去亚甲基小檗碱在制备治疗肺纤维化药物中的应用
WO2010128258A1 (fr) Combinaison antitumorale comprenant le cabazitaxel et la capecitabine
Urdang Bantam Medical Dictionary
KR960011240B1 (ko) 심부전증 치료용 약제
EP0990441A1 (en) A drug for treating diabetic nephrosis
CN109806263A (zh) 一种药物组合物及其制备方法和用途
JPS5823618A (ja) 精神分裂症を治療する組成物
DE60107559T2 (de) Kombination von carboxyalkylethern mit antihypertensiva und pharmazeutische verwendung
DE60119868T2 (de) Verwendung eines Östrogenagonisten zum Verbessern der vaskulären Gesundheit
US20040242676A1 (en) Method of mitigating the adverse effects of IL-2
JPS6277328A (ja) 循環改善剤
CN114075260B (zh) 化合物p57或其类似物用于体温降低和神经保护的用途
US20070093519A1 (en) Anti-emetic uses of cannabinoid analogs
JP3533491B2 (ja) 血管新生阻害剤
CN100378064C (zh) 苯环壬酯的活性代谢产物及其医药用途

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired